Home › Kanser sa Suso › New Jersey › Clifton
Pag-aaral pangklinika para sa Kanser sa Suso sa Clifton, NJ
Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Clifton. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Nagre-recruitPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Nagre-recruitPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi ang layo
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Nagre-recruitPhase 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi ang layo
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi ang layo
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Nagre-recruitPhase 2
- Hackensack Meridian Health, Hackensack · 7 mi ang layo
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Nagre-recruitPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi ang layo
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Nagre-recruitPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Nagre-recruitObservasyonal na pag-aaral
- John Theurer Cancer Center, Hackensack · 7 mi ang layo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Clifton
- Non-Small Cell Lung Cancer24 pag-aaral
- Kanser (lahat ng uri)15 pag-aaral
- Multiple Myeloma14 pag-aaral
- Metastatic Cancer12 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Kanser sa Ovary11 pag-aaral
- Kanser sa Baga10 pag-aaral
- Colorectal Cancer8 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Kanser ng Endometrium8 pag-aaral
- Pagkabigo ng Puso8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.